Loading...
By the Editors
The FDA has approved the first two generic forms of apixaban (brand name, Eliquis). They are the first approved generics of any direct oral anticoagulant.
The generics are approved to lower risk for stroke and systemic embolism in patients who have nonvalvular atrial fibrillation.
Comment
LINK(S):
FDA news release (Free)
Background: NEJM Journal Watch General Medicine coverage of rivaroxaban vs. apixaban (Your NEJM Journal Watch registration required)